Stanley-Laman Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-470
| Closed | -$238K | – | 267 |
|
|
2023
Q3 | $238K | Buy |
470
+19
| +4% | +$10.1K | 0.04% | 212 |
|
|
2023
Q2 | $235K | Buy |
451
+12
| +3% | +$6.48K | 0.04% | 212 |
|
|
2023
Q1 | $253K | Buy |
+439
| New | +$247K | 0.05% | 201 |
|
|
2022
Q2 | – | Sell |
-412
| Closed | -$243K | – | 307 |
|
|
2022
Q1 | $243K | Sell |
412
-723
| -64% | -$415K | 0.03% | 261 |
|
|
2021
Q4 | $757K | Sell |
1,135
-458
| -29% | -$286K | 0.09% | 210 |
|
|
2021
Q3 | $910K | Hold |
1,593
| – | – | 0.12% | 200 |
|
|
2021
Q2 | $804K | Buy |
1,593
+19
| +1% | +$8.96K | 0.11% | 196 |
|
|
2021
Q1 | $718K | Buy |
1,574
+109
| +7% | +$52K | 0.12% | 195 |
|
|
2020
Q4 | $682K | Buy |
1,465
+195
| +15% | +$91.4K | 0.12% | 191 |
|
|
2020
Q3 | $561K | Buy |
1,270
+109
| +9% | +$45K | 0.12% | 176 |
|
|
2020
Q2 | $421K | Buy |
1,161
+261
| +29% | +$87.5K | 0.1% | 193 |
|
|
2020
Q1 | $255K | Buy |
+900
| New | +$284K | 0.08% | 217 |
|
|
2019
Q4 | – | Sell |
-988
| Closed | -$288K | – | 291 |
|
|
2019
Q3 | $288K | Hold |
988
| – | – | 0.07% | 220 |
|
|
2019
Q2 | $290K | Buy |
+988
| New | +$272K | 0.07% | 228 |
|
|
2018
Q4 | – | Sell |
-28,244
| Closed | -$6.89M | – | 294 |
|
|
2018
Q3 | $6.89M | Sell |
28,244
-1,916
| -6% | -$441K | 1.69% | 7 |
|
|
2018
Q2 | $6.25M | Buy |
30,160
+127
| +0.4% | +$27K | 1.4% | 9 |
|
|
2018
Q1 | $6.2M | Sell |
30,033
-98
| -0.3% | -$20.6K | 1.41% | 9 |
|
|
2017
Q4 | $5.72M | Buy |
30,131
+861
| +3% | +$165K | 1.24% | 15 |
|
|
2017
Q3 | $5.54M | Buy |
29,270
+1,815
| +7% | +$329K | 1.48% | 13 |
|
|
2017
Q2 | $4.79M | Buy |
27,455
+830
| +3% | +$139K | 1.3% | 18 |
|
|
2017
Q1 | $4.09M | Buy |
26,625
+24,805
| +1,363% | +$3.79M | 1.11% | 23 |
|
|
2016
Q4 | $257K | Hold |
1,820
| – | – | 0.08% | 230 |
|
|
2016
Q3 | $289K | Hold |
1,820
| – | – | 0.12% | 165 |
|
|
2016
Q2 | $269K | Hold |
1,820
| – | – | 0.11% | 188 |
|
|
2016
Q1 | $258K | Sell |
1,820
-6,021
| -77% | -$807K | 0.05% | 227 |
|
|
2015
Q4 | $1.11M | Buy |
7,841
+5,794
| +283% | +$773K | 0.19% | 132 |
|
|
2015
Q3 | $250K | Sell |
2,047
-47
| -2% | -$6.12K | 0.05% | 266 |
|
|
2015
Q2 | $272K | Hold |
2,094
| – | – | 0.05% | 252 |
|
|
2015
Q1 | $281K | Buy |
2,094
+181
| +9% | +$23.3K | 0.05% | 256 |
|
|
2014
Q4 | $240K | Buy |
+1,913
| New | +$233K | 0.05% | 278 |
|
Other funds holding TMO
Stanley-Laman Group's TMO Position: Q4 2023 in Review
Stanley-Laman Group sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 470 shares — an estimated $238K sold.
Stanley-Laman Group first reported a position in TMO in Q4 2014 and held it in 30 quarters. The position peaked at $6.89M in Q3 2018. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.
- Stanley-Laman Group reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
- Stanley-Laman Group sold 470 Thermo Fisher Scientific shares in Q4 2023, an estimated $238K.
- Stanley-Laman Group first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 30 quarters.
- Stanley-Laman Group's Thermo Fisher Scientific position peaked at $6.89M in Q3 2018.
- 2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.
Based on Stanley-Laman Group's 13F filing for Q4 2023, filed 2 Feb 2024.